Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 174.66 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2023.
Eisai Co. Ltd.'s second quarter result of 45.52 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 6.86 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 45.52 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 7.09 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 174.66 Billion JPY for the item "Cost of Goods Sold Including Depreciation and Amortization" represents an increase of 1.75 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.07 percent compared to the value the year prior.
The 1 year change in percent is 11.07.
The 3 year change in percent is -6.84.
The 5 year change in percent is 1.42.
The 10 year change in percent is -12.35.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cost of Goods Sold Including Depreciation and Amortization | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cost of Goods Sold Including Depreciation and Amortization | 486,508,953,600.00 |
![]() | AbbVie Inc - Cost of Goods Sold Including Depreciation and Amortization | 399,570,305,024.00 |
![]() | Roche Holding AG - Cost of Goods Sold Including Depreciation and Amortization | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cost of Goods Sold Including Depreciation and Amortization | 280,205,508,085.11 |